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ABSTRACT
There is an increasing recognition that detailed
nucleic acid sequence information will be useful
and even required in the diagnosis, treatment and
surveillance of many significant pathogens. Because
generating detailed information about pathogens
leads to significantly larger amounts of data, it is
necessarytodevelopautomatedanalysismethods to
reduce analysis time and to standardize identifica-
tion criteria. This is especially important for multiple
pathogen assays designed to reduce assay time and
costs. In this paper, we present a successful
algorithm for detecting pathogens and reporting the
maximum level of detail possible using multi-
pathogen resequencing microarrays. The algorithm
filters the sequence of base calls from the microarray
and finds entries in genetic databases that most
closelymatch.Taxonomicdatabasesarethenusedto
relate these entries to each other so that the
microorganism can be identified. Although devel-
oped using a resequencing microarray, the approach
is applicable to any assay method that produces
base call sequence information. The success and
continued development of this approach means that
a non-expert can now perform unassisted analysis
of the results obtained from partial sequence data.
INTRODUCTION
For both surveillance and diagnostic applications, ﬁne-scale
pathogen identiﬁcation and near-neighbor discrimination is
important; therefore, an assay that monitors at this very spe-
ciﬁc level is desirable for many types of samples such as
clinical and environmental (1–3). To successfully use any
method based on DNA or RNA detection, these assays
must be coupled with large databases of nucleic acid
sequence information for assay design to ensure that the
desired information is provided and for the interpretation of
raw data. Several well-established techniques use PCR to
amplify individual target pieces of sequenced genomes to
provide detection of organisms (4). These methods can
roughly be divided into approaches that target individual
short sequence lengths or probes (<40 bp) and methods that
examine longer probes. The advantage of using short probes
is that when the uniqueness of the probe has been assured and
unique primers are also selected, this method gives good spe-
ciﬁcity. This approach is capable of providing ﬁne-scale iden-
tiﬁcation of several genetically close organisms by selecting a
sufﬁcient number of probes. However, this can rapidly lead to
a very large number of total probes being required to detect
all organisms of interest. In addition these selected probes,
which in the initial selection process were determined to be
unique, are often later found to be less speciﬁc as more organ-
isms are sequenced or are less speciﬁc under conditions that
differ from the original conditions. This is particularly a prob-
lem for organisms belonging to a family with a high mutation
rate and also for pathogens that have relatively few neighbor-
ing pathogens sequenced. In addition, PCR approaches
focused on short unique probes are not capable of detecting
the presence of new signiﬁcant mutations nor can they easily
resolve base sequence details. Approaches that use longer
individual probes avoid many of these issues at the cost of
being less speciﬁc. This issue means most of these
approaches are not suitable for providing the information
desired, providing impetus to this work.
High-density resequencing microarrays produce variable
length segments, 10
2–10
5 bp, of direct sequence information.
This target sequence falls in the longer target regime of PCR
approaches but rather than being hybridized to a longer less-
speciﬁc probe on the microarray, many shorter speciﬁc
probes are placed on the microarray to allow more detailed
determinations from the entire PCR amplicon. This also
means that the speciﬁcity of the primers used can be relaxed.
They have been successfully used to detect single nucleotide
polymorphism (SNP) and genetic variants from viral, bacte-
rial and eukaryotic genomes (5–12). Their use for SNP detec-
tion has clearly established their ability to provide reliable
quality sequence information. In most cases, the microarrays
were designed to study a limited number of genetically similar
target pathogens and for many cases, the detection methods
relied only on recognizing hybridization patterns for identiﬁ-
cation (6,9,10,13,14). Taking advantage of the sequential
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is required for SNP detection, resequencing has recently
been successfully adapted recently using a different approach
for organism identiﬁcation of multiple bacterial and viral
pathogens while allowing for ﬁne detailed discrimination of
closely related organisms and tracking mutations within the
targeted pathogen (15–16). The new methodology differed
from earlier work by using the resolved bases as the query
of a similarity search of DNA databases to identify the
most likely species and variants that match the base calls
from the hybridization observed. The system was capable
of testing for 26 pathogens simultaneously and could detect
the presence of multiple pathogens. A software program,
resequencing pathogen identiﬁer (REPI), was used to sim-
plify data analysis by performing similarity searches of a gen-
etic database using basic local alignment search tool
(BLAST) (17). The REPI program used BLAST default set-
tings and would only return sequences that might represent
the hybridization if the expect value, a quantity calculated
by the BLAST program that indicates the likelihood that
the sequence match found would have occurred by random
chance in the database, was <10
 9. This screened out all
cases that had insufﬁcient signal; however, the ﬁnal deter-
mination of what pathogen(s) was detected and to what
degree discrimination was possible required manual examina-
tion of the returned results. This method successfully allowed
ﬁne discrimination of various adenoviruses and strain identi-
ﬁcations of Flu A and B samples in agreement with conven-
tional sampling results (15,16). Two important advantages of
this approach were that the information was always recovered
at the most detailed level possible and that it was capable of
still recognizing organisms with recent mutations. This
approach also maintained speciﬁcity well, as it was not
dependent on the uniqueness of a few individual short probes.
Although this analysis method has utility, there are several
shortcomings: it is time consuming, not optimized to maxi-
mize sensitivity, has complicated results, is suitable only
for an expert, and contains redundant or duplicate informa-
tion. The process was time consuming because only the initial
screening was handled automatically while the remaining
steps required manual interpretation before the detection
analysis was complete. Because a simple criterion (expect
value cutoff of 10
 9) and non-optimized BLAST parameters
were used to consider a pathogen detected, the REPI algo-
rithm provided a list of candidate organisms but did not
make a ﬁnal simple conclusion or relate the results of one
prototype sequence to another. Instead a manual process
was used to make the ﬁnal determination, but because the
REPI program provided all similar results and the use of pub-
lic nucleic acid databases containing redundant entries, a
large amount of data was presented to a user that was not use-
ful. In addition, with a manual process it was not possible to
establish that the algorithm developed was generally applica-
ble for any organism where nucleic acid base resolved
sequence information has been provided.
In this paper, we describe a new software expert system,
Computer-Implemented Biological Sequence Identiﬁer sys-
tem 2.0 (CIBSI 2.0), that successfully uses resolved base
sequence information from custom designed Affymetrix rese-
quencing microarrays to provide a simple list of organisms
that are detected. This algorithm addresses the most important
shortcoming of previous methods by incorporating new fea-
tures to completely automate pathogen identiﬁcation. We
have demonstrated the effectiveness of this algorithm for iden-
tiﬁcation via several examples. The single program is capable
of making correct decisions for all 26 pathogens contained on
the Respiratory Pathogen Microarray v.1 (RPM v.1), whether
detected alone or in combinations, with improved sensitivity.
Although the program is currently applied to resequencing
microarrays, the methodologies developed remain generally
applicable. Only the ﬁrst portion of the algorithm handles
issues speciﬁc to microarrays while the remainder deals with
sequences that are suitable for use as a query by the BLAST
algorithm. In developing the general identiﬁcation algorithm,
we have identiﬁed and resolved issues speciﬁc to resequencing
microarrays that complicate their use. Because the entire deci-
sion process for what is detected has been automated, it is
straightforward to test whether the rules used to make identi-
ﬁcations are rigorous and applicable to any pathogen. With
this efﬁcient program, resequencing based assays can provide
a competitive method to test simultaneously for many possible
pathogens, providing output that can be interpreted by a non-
expert.
METHODS
Amplification, hybridization and sequencing
determination
The details of the RPM v.1 design and the experimental
methods have been discussed in previous work (15,16,18)
(Lin et al., submitted for publication). Brieﬂy, the RPM v.1
chip design includes 57 tiled regions allowing resequencing
of 29.7 kb of sequences from 27 respiratory pathogens and
biothreat agents. These were selected based upon clinical
relevance for the population of immediate interest (United
States military recruit in training) (19–21). Partial sequences
from the genes containing diagnostic regions were tiled for
the detection of these pathogens. The experimental microar-
ray data used in the present analysis were obtained using a
variety of puriﬁed nucleic acid templates and clinical samples
culture (throat swabs and nasal washes) using random and
multiplexed RT–PCR ampliﬁcation schemes (for more detail
description of ampliﬁcation methods see Supplementary
Data). Resequencing microarrays provide base call resolution
by comparing the intensities between a set of four 25mer
probes that differ from each other at the same position
(13th base). An amplicon or target sequence is represented
by numerous overlapping probe sets. GCOS  software
v1.3 (Affymetrix Inc., Santa Clara, CA) was used to align
and scan hybridized microarrays to determine the intensity
of each probe in every probe set. Base calls were made
based on the intensity data of each probe set using GDAS
v3.0.2.8 software (Affymetrix Inc.) which used an imple-
mentation of the ABACUS algorithm (5). The sequences
were represented in FASTA format for later analysis steps.
In this paper, target pathogens are the organisms the assay
was speciﬁcally designed to detect. The sets of probes that
represent reference sequence selected from target pathogen
genomes are referred to as a Prototype Sequence or ‘ProSeq’
for brevity. The set of resolved bases that result from hybrid-
ization of genomic material to a ProSeq is referred to as the
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possible subsequences or ‘SubSeqs’.
The CIBSI 2.0 program implemented in Perl described in
this study handled a hierarchy of three tasks (Figure 1): (I) Pro-
Seq identiﬁcation; (II) ProSeq grouping; and (III) pathogen
determination. The most developed and important portion of
the algorithm deals with ProSeq identiﬁcation Task(I) and is
handled in three important subtasks: initial ﬁltering of individ-
ualHybSeqsintoSubSeqssuitableforsequencesimilaritycom-
parisons (Figure 2), database querying of individual SubSeqs
(Figure 3) and taxonomic comparison of BLAST returns for
each SubSeq (Figure 4). The NCBI BLAST and taxonomy
databases were used for the queries and images were obtained
on February 7, 2006. For the ProSeq grouping Task(II),
ProSeqs were compared to determine if they supported the
same identiﬁed organism. In the pathogen determination
Task(III), detected organisms were compared to the list of
target pathogens the assay was designed for in order to deter-
mine if any were positively detected or were possibly related
close genetic near neighbors. The level of discrimination that
a particular sample supported was automatically determined.
ProSeq identification Task(I): subtask(I) filtering
An initial ﬁltering algorithm, REPI, was developed previ-
ously (16) and the general concepts with revisions were
incorporated into the current (automated detection) algorithm
used in the CIBSI 2.0 program. Filtering and subsequence
selection were used to remove potential biasing caused by
reference sequence choice and by other sources (i.e. primers).
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Figure 1. Schematic representation of the algorithm representing relationship of three main tasks and logic of subtasks associated with tasks. ProSeq
identification Task(I) carries out filtering and subsequence selection, and then determines what database records Subseqs are most similar to. ProSeq grouping
Task(II) figures whether prototype sequence identifications support a common organism identification. Pathogen determination Task(III) does final examination
and decisions of the detected organism from the microarray data. ProSeq: prototype sequence; SubSeq: subsequences.
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hybridized in the presence of only primers to determine loca-
tions where they resulted in hybridization. Any portions of
the ProSeqs that hybridized with the primers were masked
as N calls so that the HybSeq did not contain biased informa-
tion. Normally the primers are designed to be outside the Pro-
Seq region to minimize the interference caused by primers,
and so minimize the bases to be masked. There is still the
chance that some bases require masking because with the
large number of primers used in the multiplex, short stretches
of a ProSeq not corresponding to primer locations may still
hybridize with the primers. Such regions could be removed
from the reference sequences and so not appear on the
microarray. However, determining such locations are a difﬁ-
cult and time-consuming task that for most cases is not
worth the effort. The ﬁrst subtask of ProSeq identiﬁcation
Task(I) is noted in Figure 1 and shown schematically in detail
in Figure 2. This subtask uses a procedure to examine a Hyb-
Seq to ﬁnd the longest possible subsequence of base calls
(SubSeq) that can be submitted as a query to BLAST.
It produces a group of SubSeq that contain all portions of a
HybSeq that have a chance of producing a limited list of
returns from a BLAST query. When a HybSeq has two regions
separated by a long stretch of continuous N calls, the rela-
tional positioning of the two regions cannot be trusted and
so must be sent as separate queries. In addition for shorter sub-
sequences, the number of base calls that must be made is
dependent on the length. It was also recognized that for
very long sequences a longer WORD size in BLAST may
be used. A detailed description of the criteria and process
used for each step is contained in Supplementary Data.
Upon completion, the algorithm returned to the Task(I) loop
and performed the BLAST subtask.
ProSeq identification Task(I): subtask(II)
database query
The database query subtask performed a batch similarity
search of a database using SubSeq as the queries. The
BLAST program used was the NCBI Blastall –p blastn ver-
sion 2.12 with a deﬁned set of parameters. The masking of
low complex regions was performed for the seeding phase
to speed up the query; however, low complexity repeats
were included in the actual scoring. The entire nucleotide
database from NCBI acquired on February 7, 2006 was
used as the reference database. (Note that earlier images of
the database were used during development but all experi-
ments were rerun with the algorithm as described with the
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Figure 2. Detail schematic representation of filtering subtask of ProSeq
identification Task(I). For each ProSeq, primer regions were masked as N
(ambiguous) calls, then UniRate, was calculated from the HybSeq. For
ProSeqs, which passed the UniRate requirement, a revised sliding window
algorithm attempted to grow a SubSeq that could be used as a query to
BLAST. The identity (start location in the ProSeq and length) of a
successfully grown SubSeq was placed in a file for batch querying via
BLAST. VARI ¼ [(‘SubSeq length’   30) * 0.2857 + 70]. Detailed SubSeqs
requirement is described in Supplementary Data.
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Figure 3. Detailed schematic representation of the second subtask of ProSeq
identification Task(I), organism identification for an individual SubSeq. Each
SubSeq sent to BLAST returned a list of possible matches contained in a
Return array that was sorted through to find best bit score/expect value pair
(MaxScore). If the MaxScore was greater than MIN (10
 6), all returns that
had this best Score were sorted into a new array Rank1. Detailed SubSeqs
requirement is described in Supplementary Data.
Nucleic Acids Research, 2006, Vol. 34, No. 18 5303image of the database obtained on this date.) The default gap
penalty and nucleotide match score were used. The nucleot-
ide mismatch penalty, –q, parameter was set to  1 rather
than the default. The results of any BLAST query with an
expect value <0.0001 were returned in tabular format from
the blastall program. The information about each return (bit
score, expect value, mismatches, length of match) was placed
in the Return{hash key}{info} hash using the SubSeq identity
as the hash key for further analysis.
ProSeq identification Task(I): subtask(III) and
subtask(IV) complete ProSeq identification
The next subtask of ProSeq identiﬁcation Task(I) carried out
was the determination of SubSeq() states and is shown in
Figure 3. The BLAST algorithm gives a ranking score
which can be reported as accounting for the size of the data-
base (expect value) or not (bit score). The full taxonomic
classiﬁcations of every return for a SubSeq were retrieved
from the NCBI taxonomy database obtained on February 7,
2006. Using the scores and taxonomy relationships it was
possible to ﬁnd a reduced number of returns that had the
best match with the HybSeq. These results were summarized
by identifying the taxonomic class to which all the returns
belonged to, ‘identiﬁed organism’, and a parameter that
indicated how they are related to each other, ‘organism
uniqueness’. A detailed description of the steps is contained
in Supplementary Data.
After each SubSeq was examined, the algorithm moved
to the next subtask, which was to determine the identiﬁed
organism of the ProSeq from the SubSeq (Figure 4). The
subsequences from the same ProSeq were only allowed to
support a single ‘identiﬁed organism’ determination. The pro-
cedure shown in Figure 4 demonstrates the decision method
used to arrive at this determination (detailed description in
Supplementary Data). After the subtask covered in Figure 4
was completed, the ProSeq identiﬁcation Task(I) loop contin-
ued until all ProSeqs were examined. A list of ProSeqs that
had detected organisms was built up in the Result1 array.
ProSeq grouping Task(II)
After the ProSeq identiﬁcation Task(I) was completed, ProSeq
grouping Task(II) (Figure 1) was used to examine the identi-
ﬁed organism values listed in Result1 and grouped them
together if they identiﬁed the same taxonomic class. Each
entry in Result1 was examined and a new entry was created
in Result2 if the identiﬁed organism did not appear in this
list. The entries of Result2 represented the distinct individual
organisms identiﬁed, but might still contain redundant
information. When the ProSeqs were designed to detect the
same organism and they all hybridized well, this grouping
led to a reduction in redundant information being reported.
But, when one ProSeq did not hybridize as well for a variety
of possible reasons, multiple entries would appear in Result2
that actually represent hybridization from the same pathogen.
This is because there is an alternative cause for the ProSeq
hybridizing in this manner. This hybridization could be caused
by two different but closely related organisms both being pre-
sent in a sample and hybridizing to the microarray. Because
we have not yet developed methods to distinguish these
cases, no further reduction of the list of organisms is made
for in ProSeq grouping Task(II) in cases where the level of
identiﬁcation varied on different ProSeq targeted for the
same organism.
Pathogen determination Task(III)
Although it was difﬁcult to relate results from separate Pro-
Seqs to each other, it was desired to have a simple ﬁnal detec-
tion decision be made in pathogen determination Task(III).
The ﬁrst task was speciﬁcally implemented so that information
about what a ProSeq was intended to detect was not consid-
ered and the second task only minimal consideration of this
was taken into account. This allowed these initial tasks to be
capable of recognizing not only just positive and negative
identiﬁcations of target pathogens but also cases that were
indeterminate. In the ﬁnal task, the algorithm considered
whether the identiﬁed organisms belonged to the list of organ-
isms the ProSeqs were designed to detect. The task would
group organisms from ProSeq grouping Task(II) together
that belonged to or were child classes of the taxonomic class
of a target organism. The taxonomic class reported was the
common taxonomic group of all the organisms. When all the
ProSeqs for a pathogen hybridized well, a ﬁne level discrim-
ination was reported. But if one or more ProSeqs hybridized
less well, the reported positive target pathogen was only iden-
tiﬁed at the level of the less detailed level. This is conservative
because methods have not yet been developed to clearly dis-
criminate mixtures of very closely related organisms causing
different ProSeqs to hybridize from variable hybridization of
a single organism on several ProSeqs. The results of all
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Figure 4. Schematic representation of the third subtask of ProSeq
identification Task(I), which determines the organism, determined for a
ProSeq based on the results found for its SubSeq. All of the SubSeq of a
particular ProSeq are compared to determine the two best scoring SubSeq.
When there was a single SubSeq or one scored much better than the other, the
ProSeq inherited the properties of that SubSeq. Detailed SubSeqs requirement
is described in Supplementary Data.
5304 Nucleic Acids Research, 2006, Vol. 34, No. 18three tasks were reported and a more experienced user can
view ProSeq grouping Task(II) results to clarify some cases.
Note that organisms identiﬁed in ProSeq grouping Task(II)
that only belonged to target pathogens were reported as posi-
tives. Clear negative ProSeqs were not mentioned in the out-
put. ProSeqs that were indeterminate or that detected close
genetic organisms were never reported as positives. These
organisms were instead reported as being detected.
RESULTS
Aresequencingmicroarray(RPMv.1)wasdesignedpreviously
fordetectionandsequencetypingof20commonrespiratoryand
6 CDC category A biothreat pathogens known to cause febrile
respiratoryillnessbasedonProSeqswithoutrelyingonpredeter-
mined hybridization patterns (15,16,18). Approximately 4000
RPM v.1 experiments performed using different ampliﬁcation
schemes, single and multiple pathogen targets, puriﬁed nucleic
acids and clinical samples were examined in order to develop
the pathogen identiﬁcation algorithm. Results using this algo-
rithm with clinical samples, identiﬁed pathogens and puriﬁed
nucleic acids are discussed in detail in other works (15,16,18)
(Linetal.,submittedforpublication).Inallcases,thealgorithm
correctly identiﬁed the organism at a species or strain level,
depending on the length of the ProSeqs represented on the
RPMv.1.Somespeciﬁcexampleswillbediscussedtoillustrate
how the algorithm performs under a variety of conditions.
Pathogen identification
PuriﬁedChlamydiapneumoniaenucleicacidsampleswith10–
1000 genome copies (via method in Lin et al., submitted for
publication) were chosen to illustrate how pathogen detection
and identiﬁcation were done when multiple ProSeqs were tar-
geted for the same pathogen. RPM v.1 has three highly con-
served ProSeqs selected from the genes encoding for the
major outer membrane proteins VD2 and VD4, and the
DNA-directed RNA polymerase (rpoB) gene. The HybSeqs
from the different samples differed only in the number of
unique base calls as shown in Table 1. The percentage of the
ProSeq called varied from 80 to 100% except for one case at
a concentration of 10 that had only 11% of the rpoB ProSeq
producing unique base calls. Because the samples at this con-
centrationarenotreproduciblygeneratingthesamepercentage
of base calls, this is probably the detection limit of this ProSeq
of the assay. Table 1 listed the determinations made for the
SubSeq and at the end of each task for the various samples.
TheProSeqfromthedifferentcasesproducedthesamenumber
of SubSeqs. These SubSeqs from different samples reported
different bit scores for the same top ranked returns from
BLAST. In fact VD2 and VD4 produced exactly the same
results. The NCBI taxonomy database classiﬁed the returns
into four distinct groups, which represented the C.pneumoniae
taxonomic group and three child strain groups. AE001652,
AE002167, AE017159 and BA000008 appeared in the returns
of allthe ProSeqs foreach sample,sincethey represented data-
base entriesofcompletelysequenced genomes. One rpoBSub-
Seqproducedforitsorganismuniqueness,SeqUniqu.All other
SubSeqs were TaxAmbig as multiple returns from different
taxonomic classes were returned. Since the VD2 and VD4
ProSeq each have a single SubSeq, Task(I) assigned the Pro-
Seq the state of the SubSeq. For the rpoB ProSeq, the bit score
of one SubSeq was large enough that the algorithm assigned
that SubSeq’s identiﬁcation to the ProSeq. Task II of the algo-
rithm grouped all three ProSeqs together since they all had the
same identiﬁed organism and TaxAmbig was assigned. The
result of Task(III) was positive for target pathogen C.pneumo-
niae and this decision was straightforward as all the ProSeqs
agreed with each other and belonged to the same target patho-
gen taxonomic class. Although the rpoB ProSeq was
SeqUniqu, this was not the ﬁnal conclusion for Task(II) as
the ProSeq that was SeqUniqu was not the child taxonomic
Table 1. Algorithm decisions for C.pneumoniae at several concentrations for SubSeq, ProSeq identification Task(I), ProSeq grouping Task(II) and pathogen
determination Task(III)
Genome
copies
ProSeq Unique
calls (%)
No. of
SubSeq
SubSeq organism identification
and Uniqueness, Bit score
Task(I) Task(II) Task(III)
1000 VD2 89 1 C. pne
(G1), TA, 145 C. pne TA C. pne TA POSITIVE C. pne
VD4 91 1 C. pne
(G1), TA, 145 C. pne TA
80 2 C. pne
(G2), SU, 307 C. pne SU
rpoB C. pne
(G3), TA,7 3
100 VD2 100 1 C. pne
(G1), TA, 164 C. pne TA C. pne TA POSITIVE C. pne
VD4 97 1 C. pne
(G1), TA, 156 C. pne TA
80 2 C. pne
(G2), SU, 343
rpoB C. pne
(G3), TA,8 7 C. pne SU
100 VD2 83 1 C. pne
(G1), TA, 136 C. pne TA C. pne TA POSITIVE C. pne
VD4 91 1 C. pne
(G1), TA, 145 C. pne TA
84 2 C. pne
(G2), SU, 318
rpoB C. pne
(G3), TA,8 2 C. pne SU
10 VD2 100 1 C. pne
(G1), TA, 164 C. pne TA C. pne TA POSITIVE C. pne
VD4 97 1 C. pne
(G1), TA, 156 C. pne TA
90 2 C. pne
(G2), SU, 340
rpoB C. pne
(G3), TA,8 9 C. pne SU
10 VD2 100 1 C. pne
(G1), TA, 164 C. pne TA C. pne TA POSITIVE C. pne
VD4 93 1 C. pne
(G1), TA, 148 C. pne TA
rpoB 11 0 Null Null
(G1) J138 (BA000008), AR39 (AE002167),Tw-183 (AE017159), C. pne (M69230, AF131889, AY555078, M64064, AF131229, AF131230); (G2) C. pne
(S83995); (G3) J138 (BA000008), AR39 (AE002167), Tw-183 (AE017159).
SU abbreviation for SeqUniqu; TA abbreviation for TaxAmbig; TU abbreviation for TaxUniqu.
Nucleic Acids Research, 2006, Vol. 34, No. 18 5305group and other ProSeq were TaxAmbig. The three recognized
strains scored the same, which indicated that the sequence
selected for the ProSeqs was very conserved and would not
allow discrimination between the strains.
Inﬂuenza and Human Adenovirus (HAdV) were the only
pathogens that had ProSeq selected that would permit detailed
strain level discrimination as discussed in previous work
(15,16). This previous work using manual analysis found
that the microarray results were in excellent agreement with
the conventional sequencing results for clinical samples.
A few of the results of running the CIBSI 2.0 program using
the updated NCBI database on the raw microarray results
are presented in Table 2 (the results for all samples used in
the previous work are presented in Supplementary Table A).
The identiﬁed organisms were not identical to the original
ﬁndings due to the difference in database used and because
all ProSeqs were considered rather than only the Flu A and
B hemagglutinin. In fact, the conventional sequencing results
that were submitted to NCBI from that work were found for
every sample to be among the returns with the best score for
the hemagglutinin ProSeq (Supplementary Table B). It should
be noted that the previous work based its analysis upon only
the results of the hemagglutinin ProSeq. For 8 of 13 Inﬂuenza
A and 3 of 12 Inﬂuenza B cases, the results of ProSeq identi-
ﬁcation Task(I) and ProSeq grouping Task(II) found that the
conventional sequencing was the single best return for the
hemagglutinin ProSeq. Owing to the large number of isolate
sequences in the database for the hemagglutinin gene it was
not surprising that in some cases a single unique entry was
not found. In each of the remaining ﬁve Inﬂuenza A samples,
the other sequences returned differed by <0.2% from the
conventional sequence. The fewer samples with unique
isolate identiﬁcations for Inﬂuenza B were due to an older ref-
erence sequence used for the ProSeq, which allowed less
Table 2. Algorithm decisions for Influenza A clinical sample identified previously using a manual method for SubSeq, ProSeq identification Task(I), ProSeq
grouping Task(II) and pathogen determination Task(III)
Sample name ProSeq No. of
Sub
SubSeq organism identification
and Uniqueness, Bit score
Task(I) Task(II) Task(III)
A/Colorado /360/05 HA3 1 H3N2 TA,1031 H3N2 TA (NY) SU H3N2 TA POSITIVE H3N2
NA2 1 A/NewYork/98/04(NY) SU,1570 (NY) SU
M 4 2 Flu A TA,69.7 128 H3N2 TA
2 H3N2 TA,125 393
A/Qatar /2039/05 HA3 1 A/Qatar/2039/05(QA) SU,1080 (QA) SU (QA) SU H3N2 TA POSITIVE H3N2
NA2 2 2 H3N2 TA,643 919 H3N2 TA
M 4 2 H3N2 TA,505 272 H3N2 TA
2 Flu A TA,115 77.7
A/Guam /362/05 HA3 1 A/Guam/362/05(GA) SU,1066 (GA) SU (GA) SU H3N2 TA POSITIVE H3N2
NA2 1 H3N2 TA,1610 H3N2 TA
M 4 2 H3N2 TA,240 397 H3N2 TA
2 Flu A TA,79.2 79.2
A/Italy /384/05 HA3 1 A/Italy/384/05(IT) SU, 1017 (IT) SU (IT) SU (NY) SU H3N2 TA POSITIVE H3N2
NA2 1 A/NewYork/371/04(NY) SU,1494 (NY) SU
M 3 2 H3N2 TA, 461 359 H3N2 TA
Flu A TA,74.5
A/Turkey/2108/05 HA3 1 A/Turkey/2108/05(TU) SU,952 (TU) SU (TU) SU H3N2 TA POSITIVE H3N2
NA2 1 H3N2 TA,1363 H3N2 TA
M 3 2 H3N2 TA,412 239 H3N2 TA
Flu A TA,76.1
A/Korea/298/05 HA3 1 A/Korea/298/05(KO) SU,1011 (KO) SU (KO) SU (NY) SU H3N2 TA POSITIVE H3N2
NA2 3 A/NewYork/98/04(NY) SU,243 (N1) SU
2 Flu A TA,110 98.3
M 4 2 Flu A TA,66.6 76.1 H3N2 TA
2 H3N2 TA,328 255
A/Japan /1383/05 HA3 1 A/Japan/1383/05(JA) SU,935 (JA) SU (JA) SU H3N2 TA POSITIVE H3N2
NA2 1 H3N2 TA,1369 H3N2 TA
M 5 3 Flu A TA,125 114 76.1 H3N2 TA
2 H3N2 TA,175 247
A/Ecuador /1968/04 HA3 1 H3N2 TA,1071 H3N2 TA H3N2 TA POSITIVE H3N2
NA2 2 H3N2 TA,1584 109 H3N2 TA
M 4 3 Flu A TA,158 164 104 H3N2 TA
H3N2 TA,131
A/Iraq /34/05 HA3 1 A/Iraq/34/05(IR) SU,1028 (IR) SU (IR) SU H3N2 TA POSITIVE H3N2
NA2 3 2 H3N2 TA,125 1402 H3N2 TA
Flu A TA,109
M 5 3 H3N2 TA,137 350 234 H3N2 TA
2 Flu A TA,131 74.5
A/Peru /166/05 HA3 1 A/Peru/166/05(PU) SU,1061 (PU) SU (PU) SU H3N2 TA POSITIVE H3N2
NA2 1 H3N2 TA,1686 H3N2 TA
M 3 H3N2 TA,508 H3N2 TA
Flu A TA,76.1
A/NewYork/461/2005 SU,247
Note: Within a row the first listing of a specific strain was followed by a two-letter abbreviation used in the remaining columns of that row.
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ple sequences were returned for a sample they represented
greater genetic variation, up to 2%. As a result of the current
method of making pathogen determination Task(III) level
identiﬁcation, the ﬁnal organism reported was less speciﬁc
(H3N2 or Flu B) for every sample than what was reported as
possible in ProSeq grouping Task(II). For HAdV samples, the
algorithm also reproduced the ﬁner scale discriminations that
hadbeenmadepreviouslybymanualmethods(datanotshown).
The next example of detection for the Mycoplasma pneu-
moniae pathogen demonstrated a case where there was only
a single ProSeq for the target pathogen. A total of 48 test
samples were performed using multiplex PCR (via method
in Lin et al., submitted for publication) where for 46 of the
samples M.pneumoniae organism was spiked into nasal
wash with several other pathogens from 100 to 100000 col-
ony forming units per ml, the remaining 2 samples were puri-
ﬁed with nucleic acid from culture stock at a concentration of
1000 genome copies per reaction volume. This ProSeq was
also not optimal for ﬁne discrimination because it was
selected from a highly conserved region (345 bp) of the
cytadhesin P1 gene. In every case taxonomic database entries
for M.pneumoniae or its one recognized distinct strain tied for
MaxScore (Supplementary Table 3). To better understand
these returns, the database sequences were examined and sub-
divided into three groups of sequences, A, B and C, based on
how well they matched the reference sequence used to make
the ProSeq. The placement of the database entries into the
three groups was determined from a CLUSTAL alignment
of the sequences of this gene. This alignment conﬁrmed
that the database entries differed signiﬁcantly more from
each other in regions not represented by the ProSeq and con-
tained sufﬁcient variability that would have allowed ﬁner dis-
crimination. Members of Group A exactly matched the
ProSeq and could not be distinguished between on the
microarray. Similarly, members of group B matched the Pro-
Seq except at the 199th position where the base called was C
rather than T. Group C sequences contained a few database
entries that were more variable and might be distinguished
from other entries within the ProSeq. For the 48 experimental
tests of M.pneumoniae, as much as 80% of the ProSeq
hybridized for 19 samples, yet only 5 of these samples had
an unambiguous base call at the 199th position. When it
was unambiguous, it always matched group B sequences. In
the cases where an N base call was made at the 199th loca-
tion, both groups A and B sequences were returned with
the same score. Regardless of this, the target pathogen posi-
tively identiﬁed was M.pneumoniae for every sample tested.
These examples showed how decisions were made inde-
pendent of whether single or multiple ProSeqs were dedicated
to a target pathogen. They also illustrated that the level of dis-
crimination possible was strongly determined by the quality
of the selected ProSeq. It is possible that for some pathogens
ﬁne level discrimination is not required and the currently
tested selections on RPM v.1 would provide satisfactory
information. The CIBSI 2.0 algorithm demonstrated its capa-
bility to automatically report the maximum level of discrim-
ination that could be supported by the HybSeq information.
Genetic near neighbors
To demonstrate how the algorithm handled closely related
genetic species, a sample of a non-targeted pathogen was
considered using multiplex PCR (via method in Lin et al.,
submitted for publication). For Variola major virus, one of
the biothreat pathogens on the RPMv.1, the validation runs
demonstrated that Variola major virus puriﬁed DNA tem-
plates of plasmids were always positively identiﬁed when
detected (Table 3). Table 4 shows the results when puriﬁed
Vaccinia genomic DNA was spiked into nasal washes and
processed at various concentrations using multiplex PCR.
The array has two ProSeqs from hemagglutinin (VMVHA,
 500 bp) and cytokine response modiﬁer B (VMVcrmB,
 300 bp) genes for Variola major virus detection. The per-
centage of the ProSeq that hybridizes is sufﬁcient that if
hybridization patterns were only considered one might
assume that this tile is identifying the presence of its target.
This would indicate that reference sequence selected was
Table 3. Organism identification and algorithm decisions from Variola Major virus Nucleic Acid templates for SubSeq, ProSeq identification Task(I), ProSeq
grouping Task(II) and pathogen determination Task(III)
Genome
copies
ProSeq Unique
calls (%)
No. of
SubSeq
SubSeq organism identification
and Uniqueness, Bit score
Task(I) Task(II) Task(III)
1000 CRMB 83.90 1 Variola TA 355 Vari., TA Vari., SU Positive
HA 77.00 1 Variola SU 567 Vari., SU Vari., TA Variola
1000 CRMB 80.90 1 Variola TA 342 Vari., TA Vari., SU Positive
HA 75.50 1 Variola SU 554 Vari., SU Vari., TA Variola
1000 CRMB 76.40 1 Variola TA 324 Vari., TA Vari., SU Positive
HA 73.30 1 Variola SU 538 Vari., SU Vari., TA Variola
1000 CRMB 80.10 1 Variola TA 339 Vari., TA Vari., SU Positive
HA 74.90 1 Variola SU 551 Vari., SU Vari., TA Variola
1000 CRMB 81.60 1 Variola TA 345 Vari., TA Vari., SU Positive
HA 76.10 1 Variola SU 561 Vari., SU Vari., TA Variola
1000 CRMB 77.90 1 Variola TA 329 Vari., TA Vari., SU Positive
HA 75.50 1 Variola SU 556 Vari., SU Vari., TA Variola
1000 CRMB 81.60 1 Variola TA 299 Vari., TA Vari., TU Positive
HA 74.90 4 Variola TU 106 84 Vari., TU Vari., TA Variola
Variola TA 103 69.7
100 CRMB 84.20 1 Variola SU 624 Vari., SU Vari., SU Positive
HA 5.60 0 Null Null Variola
TA, TaxAmbig in this case Variola, Variola major and minor taxonomic classes.
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none of the samples is in fact identiﬁed as Variola major or
minor virus. Vaccinia was always one of the Orthopoxvirus
species listed with the highest scores for VMVcrmB ProSeq,
but in only seven cases was it uniquely identiﬁed as the proba-
ble species detected. In only one sample at the lowest concen-
tration and fraction of VMVcrmB hybridizing, did this ProSeq
even identify Variola major and minor virus as one among the
Orthopoxvirus species that could be the cause of the hybrid-
ization. The lower limit of detection for the ampliﬁcation
method used was between this concentration and the one
above it for Variola major itself. The VMVHA ProSeq exhib-
ited much lower sensitivity and made identiﬁcations of
Orthopoxvirus species in only two experiments and Variola
major virus was listed as one of the tied best scoring returns.
In both cases, VMVcrmB ProSeq speciﬁcally identiﬁed Vac-
cinia virus as the best match. The percentage of the hybridized
ProSeq correlated with concentration of the sample.
Filtering
This example demonstrated the importance of the ﬁltering
portion of the algorithm by considering the HybSeqs of the
ProSeqs for the H1N1 neuraminidase (NA1) and matrix
genes from human Inﬂuenza A/Puerto Rico/8/34 (H1N1)
strain. Filtering was necessary because sending the HybSeq
of a ProSeq to BLAST in a single query can bias the scores
against strains that have insertions or deletions relative to the
ProSeq, especially when using BLAST parameters that maxi-
mized the use of base calls. The sliding window test was the
portion of the algorithm that controlled ﬁltering. If ﬁltering
were turned off, the entire HybSeq would be used in a single
subsequence for two inﬂuenza ProSeqs that showed signiﬁ-
cant hybridization. A/Weiss/43 (H1N1) strain was identiﬁed
as the most likely strain from the HybSeq of the NA1 ProSeq
while the HybSeq of the matrix ProSeq correctly identiﬁed
A/Puerto Rico/8/34. To better understand the source of bias-
ing, CLUSTAL alignment of the NA1 gene of the two strains
and the reference sequence used to make the ProSeq are
shown in Figure 5. The two strains showed 95% identity
(67 mismatches in 1362 aligned bases); however, there was
a stretch of 45 bases inserted in both A/Weiss/43 and the
NA1 ProSeq compared to A/Puerto Rico/8/34. With the
default ﬁltering on, the NA1 ProSeq was split into ﬁve Sub-
Seqs as the algorithm encountered large stretches of no calls.
Table4. Organism identification and algorithm decisions from Vaccinia sample on Variola Major virus ProSeqs for SubSeq, ProSeq identification Task(I), ProSeq
grouping Task(II) and pathogen determination Task(III)
CFU ProSeq Unique
calls (%)
# SubSeq SubSeq organism identification
and Uniqueness, Bit score
Task I Task II Task III
5 · 10
7 CRMB 77.90 2 Orth.
TA 156
(H1), Vacc.
TU 153
(H2) Vacc., TU Vacc., TU Detected
HA 29.40 1 Orth.
TA 60.2
(H3) Orth., TA Orth., TA Vaccinia
5 · 10
7 CRMB 79.80 2 Orth.
TA 164
(H1), Vacc.
TU 115
(H2) Vacc., TU Vacc., TU Detected
HA 25.70 1 Orth.
TA 66.6
(H3) Orth., TA Orth., TA Vaccinia
1.6 · 10
7 CRMB 79.40 2 Orth.
TA 161
(H1), Vacc.
TU 114
(H2) Vacc., TU Vacc., TU Detected
HA 14.80 0 Null Null Vaccinia
1.6 · 10
7 CRMB 77.50 2 Orth.
TA 153
(H1),109
(H4) Orth., TA Orth., TA Detected
HA 24.50 0 Null Null Orthopox
1.6 · 10
7 CRMB 76.80 2 Orth.
TA 155
(H1), Vacc.
TU 112
(H2) Vacc., TU Vacc., TU Detected
HA 21.60 0 Null Null Vaccinia
1.6 · 10
7 CRMB 74.50 2 Orth.
TA 152
(H1), 106
(H5) Orth., TA Orth., TA Detected
HA 17.30 0 Null Null Orthopox
5 · 10
6 CRMB 77.90 2 Orth.
TA 155
(H1), Vacc.
TU 112
(H2) Vacc., TU Vacc., TU Detected
HA 25.70 0 Null Null Vaccinia
5 · 10
6 CRMB 78.30 2 Orth.
TA 153
(H1), 115
(H5) Orth., TA Orth., TA Detected
HA 22.00 0 Null Null Orthopox
5 · 10
6 CRMB 73.00 2 Orth.
TA 150
(H1), Vacc.
TU 99.9
(H2) Vacc., TU Vacc., TU Detected
HA 13.00 0 Null Null Vaccinia
5 · 10
6 CRMB 73.40 2 Orth.
TA 153
(H1), 115
(H5) Orth., TA Orth., TA Detected
HA 7.80 0 Null Null Orthopox
1.6 · 10
6 CRMB 75.30 2 Orth.
TA 158
(H1), 107
(H5) Orth., TA Orth., TA Detected
HA 8.60 0 Null Null Orthopox
1.6 · 10
6 CRMB 49.80 2 Orth.
TA 60
(H1), Vacc.
TU 90.3
(H2) Vacc., TU Vacc., TU Detected
HA 6.60 0 Null Null Vaccinia
1.6 · 10
6 CRMB 65.50 2 Orth.
TA 136
(H1), 91.9
(H5) Orth., TA Orth., TA Detected
HA 10.00 0 Null Null Orthopox
1.6 · 10
6 CRMB 62.90 2 Orth.
TA 126
(H1), 87.2
(H5) Orth., TA Orth., TA Detected
HA 8.20 0 Null Null Orthopox
5 · 10
5 CRMB 58.40 2 Orth.
TA 110
(H1), 90.3
(H5) Orth., TA Orth., TA Detected
HA 9.00 0 Null Null Orthopox
5 · 10
5 CRMB 56.20 2 Orth.
TA 77.7
(H6), 96.7
(H5) Orth., TA Orth., TA Detected
HA 8.00 0 Null Null Orthopox
5 · 10
5 CRMB 49.00 1 Orth.
TA 87.2
(H5) Orth., TA Orth., TA Detected
HA 9.30 0 Null Null Orthopox
5 · 10
5 CRMB 44.60 1 Orth.
TA 90.3
(H5) Orth., TA Orth., TA Detected
HA 7.80 0 Null Null Orthopox
Vacc., Vaccinia; Orth., Orthopox. (H1) Rabbitpox, Buffalopox, Cowpox, Vaccinia, Callithrix jacchus, Taterapox. (H2) Vaccinia. (H3) Vaccinia, Variola (Major
and Minor), Cantagalo, Ectromelia, Elephantpox, Aracatuba, Cowpox, Taterapox. (H4) H2 and Cowpox. (H5) H4 and Camelpox. (H6) H1 and Variola, Variola
Major, Variola Minor.
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that three of the SubSeqs, which were shorter, had an identi-
ﬁed organism of H1N1 as several isolates including A/Puerto
Rico/8/34 tied with the best score, while the two other Sub-
Seqs had an identiﬁed organism of only the A/Puerto Rico/
8/34 strain as being the closest match. The organism identi-
ﬁed by the NA1 ProSeq was A/Puerto Rico/8/34 because
one of the SubSeqs had a much higher score. This ProSeq
supported the same strain identiﬁcation made in the matrix
ProSeq. The organism identiﬁed was A/Puerto Rico/8/34
because two ProSeqs detected only that organism. The correct
target pathogen was detected with ﬁltering while without ﬁl-
tering the target pathogen level of identiﬁcation would have
been Inﬂuenza A (H1N1 subtype) because two organisms
were detected, A/Puerto Rico/8/34 and A/Weiss/43. Splitting
the HybSeq into SubSeqs to remove biasing may reduce the
level of identiﬁcation as occurred for the three of the ﬁve
SubSeqs in this case. The previous example for Vaccinia
was another instance where the wrong species (Camel Pox
or Callithrix jacchus) identiﬁcation would occur if the ﬁlter-
ing was not used. Clinical samples in Table 2 showed that
HybSeqs split into multiple SubSeqs were capable of very
speciﬁc identiﬁcation.
To illustrate the other ﬁltering performed, when multiplex
strategies rather than generic were used for ampliﬁcation
Figure 5 also contains the raw and mask ﬁltered results of
this region for the A/Puerto Rico/8/34 sample. It was neces-
sary to perform additional ﬁltering to remove potential bias-
ing caused by the speciﬁc primers as described in the
methods. In the case shown in Figure 5, a sequence of 18
bases present in the raw result are made N after ﬁltering
since they are in a location that interacts with the primers.
If these base calls were included in the subsequences con-
structed, even though the HybSeq would still be split into
the same number of SubSeq, the query for the ProSeq
would favor an incorrect strain.
DISCUSSION
The algorithm we have developed successfully provided
pathogen identiﬁcation to the maximum level of detail possi-
ble (species or strain) depending on the quality of each Pro-
Seq. This identiﬁcation capability requires minimal input on
the identity of the pathogens, making non-expert use feasible.
The crucial feature incorporated that allowed complete
automation was the use of taxonomic databases, which clas-
sify organisms into ordered groups and provide relationships
between organism entries, allowing removal of redundancies,
comparison of different related prototype sequences and sim-
pliﬁcation of data presentation. This allows databases, i.e.
NCBI, that are redundant and subject to minimal curation
but which constantly receive updated and new sequence
information to be used with great success. Although we
have demonstrated this using only the NCBI databases,
other databases or custom made ones could have easily
been used, which might improve performance. The algorithm
is capable of providing accurate identiﬁcations at all analysis
levels for pathogens that are less variable or are represented
by highly conserved ProSeqs. For more variable or rapidly
mutating pathogens, e.g. Inﬂuenza A virus, ProSeq identiﬁca-
tion Task(I) and ProSeq grouping Task(II) still provided
accurate detailed identiﬁcations, but the pathogen determina-
tion Task(III) was unable to report ﬁne scale discrimination.
The comparison of the conventionally sequenced Inﬂuenza
virus gene sequences illustrated that the algorithm is capable
of automatically adjusting for updates in databases. The algo-
rithm demonstrated its capability to properly distinguish
hybridizations on a ProSeq caused by the speciﬁed pathogen
from those caused by genetically close (near neighbor) strains
and did not make incorrect identiﬁcations, eliminating one
potential cause of false positives. Filtering the raw hybridiza-
tion results served to reduce the computation time, accounted
for potential primer interference and more importantly
reduced potential biasing. This simple integrated algorithm
provided sufﬁcient and accurate identiﬁcation, so that imme-
diate use of the RPM v.1 or similar resequencing arrays and
assay is possible. Although not discussed in this paper, the
algorithm has successfully detected the presence of simulated
multi-infections (Lin et al., submitted for publication). The
algorithm as currently developed will detect mixtures when
the organisms have sufﬁcient variation; however, detection
of a mixture of an organism and its mutation strain in a sam-
ple is uncertain in its present phase. In principle it may be
possible to detect such mixtures as the resequencing microar-
ray can detect and sequence diploid organisms.
Besides demonstrating the success of the CIBSI 2.0 pro-
gram, the work involved in developing the algorithm allowed
insight into the importance of proper ProSeq selection. The
RPM v.1 was the ﬁrst resequencing array designed speciﬁc-
ally for multiple pathogen detection using database similarity
searching and served as a prototype for this application. We
have demonstrated that a single ProSeq with as few as 100 bp,
when designed correctly, can be sufﬁcient to unambiguously
identify an organism. However, it is clearly indicated that
several longer ProSeqs provide better conﬁrmation and
more detailed information of a pathogen. Although the algo-
rithm provides accuracy equivalent to manual analysis for
determinations of individual ProSeqs, the current algorithm
is only partially successful in integrating information from
multiple ProSeqs. The emphasis of the design to this point
has been on capabilities that are generally applicable to any
pathogen. We are incorporating these insights in our newer
more comprehensive resequencing array designs. Improving
Figure 5. Alignment of the influenza A NA1 ProSeq and A/Weiss/43, A/PuertoRico/8/34 strains. Raw and filtered hybridization chip results of A/puertoRico/8/
34 are also shown. Asterisks indicate perfectly matched sequences.
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Task(III) will require more information about an individual
pathogen and may have to be developed for each speciﬁc
pathogen or class of pathogens. This information is also
required for the algorithm to identify which differences
between a sample and database entries represent signiﬁcant
mutations. Future work will involve improving the use of
the current taxonomic database or potentially developing a
new relational database that is speciﬁc to our needs and
then incorporating more speciﬁc information of target patho-
gens. The hierarchal design of the data analysis makes it easy
to incorporate analysis that build upon the analysis already
performed.
We have met with some success in the current version but
want to have increased automated discrimination. We have a
well-deﬁned path to completing this aim. The use of properly
designed resequencing microarrays and this automated detec-
tion algorithm provides a way forward to developing assays
that can test for multiple organisms simultaneously while pro-
viding ﬁne strain level discrimination giving access to
information about detailed strain recognition, antibiotic resis-
tance markers and pathogenicity. This is a capability that other
approaches cannot currently provide. In addition, since the
design of the original 30 kb RPM microarray, the possible
sequence content of the current array has increased 10-fold
to 300 kb and further increases in array density are still attain-
able. This, coupled with our identiﬁcation algorithms, will
allow the analysis of partial sequence information from even
more organisms for applications such as differential diagnost-
ics for illnesses with multiple potential causes (i.e. febrile res-
piratory illness), tracking of emergent pathogens, distinction
of biological threats from harmless near genetic neighbors in
surveillance applications and for tracking the impact of co-
infections or super infections. The concept of categorizing
and reporting different degrees of identiﬁcation depending
on the quality of samples and set of target sequences is not
limited to resequencing microarrays but is more generally
applicable to any platform that is capable of returning
sequence level calls that can be used to query a reference
DNA database. As the trend for assays that test for multiple
pathogens increases, automated analysis tools, such as this
one, become more crucial for rapid identiﬁcation in simple
formats useful to the non-expert on a day to day basis. The
remaining hurdle to using resequencing microarrays as a rou-
tine assay method is now clearly the sample processing meth-
ods. Further automating these steps is an important area of
future research and development.
The program can be obtained free of charge for research
purposes by contacting the authors.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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